Experimental Ebola Vaccine From GlaxoSmithKline Approved for Testing On Humans

British drugmaker GlaxoSmithKline's (LON:GSK) (NYSE:GSK) experimental Ebola vaccine was approved for testing on human beings, even as the death toll from the deadly virus continues to increase. Bloomberg reported that the US Food and Drug Administration (FDA) gave its nod to conduct a phase 1 trial, which is the first test of a drug or vaccine in humans to assess safety and efficacy.